New Delhi: When we talk about healthcare technology, the conversation often begins with an innovative device, artificial intelligence or the latest digital advancement. But patients do not experience technology in isolation. They experience better diagnosis, safer treatment, faster recovery and a more seamless healthcare journey. That distinction is critical as healthcare systems look to medical technology not just for innovation, but for meaningful impact across the care continuum.
The real question, then, is not simply whether a technology is innovative, but when it becomes meaningful. Is it at the point of invention? At the stage of hospital adoption? Or only when patients consistently experience better outcomes? At Medtronic, we believe meaningful innovation is defined by its ability to become part of the clinical and patient journey, creating value that can be adopted, scaled and sustained.
This perspective was at the heart of the panel discussion From Innovation to Impact: Role of MedTech in Building the Future of Healthcare at the Economic Times Healthcare Leaders’ Summit 2026. Moderated by Mandeep Singh Kumar, Vice President and Managing Director, Medtronic India Subcontinent Countries, the session brought together leaders from across the healthcare ecosystem, including Mr. Vipul Jain, CEO, CK Birla Hospitals, Dr. Randeep Wadhawan, Chairman of GI, Minimal Access and Bariatric Surgery, Max Hospital, Dwarka; and Dr. Ritu Mittal Garg, Chief Growth and Innovation Officer, Fortis Healthcare. The conversation explored the intersection of technology, clinical adoption, operational workflows and healthcare economics required to translate innovation into sustainable, scalable patient care.For innovation to matter, it must first demonstrate value for the patient. Dr Wadhawan said, “From a clinician’s perspective, I think innovation should not be adopted because it’s new and there is enthusiasm around it but it should be clinically evident and clinically beneficial to the patient.”
The evolution of surgical technology shows how this can happen. Over time, advances in surgical stapling have improved procedural security and reduced complications, while newer technologies have also helped shorten the learning curve. When technology is supported by data, backed by training and integrated thoughtfully into practice, adoption becomes safer and more effective.
But clinical value alone is not enough. The next challenge is embedding innovation into everyday hospital care. Even strong pilots can face challenges when scaled across a hospital. Dr Garg said, “Many times the technology comes from somebody who believes in it, one centre can adopt it very successfully, but the idea to scale it up across the network, for even the simplest of solutions, is a bit of a challenge. I think there are two ways to do it. First, and most important, is the mindset. Organisations must have innovation and forward-thinking in their DNA.”
Garg added, “After that is the focus and the process to be able to do it. Typically, healthcare is very tactical in its own micro-systems every single day. Everybody is caught up in what’s happening today, and the mind-space to think medium- and long-term gets very limited. So you need to create a function, or a space, or a system that can take a step back with a wider, longer-term view.”
Workflow integration, staff training, nursing and technician capability, IT integration, interoperability and standardized protocols all shape whether a technology can be implemented successfully and sustained over time.
This is especially important when innovation must move beyond a single centre of excellence. Healthcare organizations operating across geographies and hospital formats need a structured approach to identifying, testing and scaling new technologies. Dedicated spaces to evaluate emerging solutions, early involvement of clinicians and business teams, and the sharing of successful outcomes across the network can help turn individual innovation into system-wide transformation.
Scaling advanced technologies also requires looking beyond conventional measures of return on investment. Jain said this isn’t always simple. “Some things are easy; high on financial viability and high on clinical impact, that’s an easy answer. But there are things which are high on clinical excellence and low on financial viability. Here, it’s important that we don’t look at viability only in the short term, and that we don’t hold it to an exceptionally high bar. Sometimes the return on capital may not be 25%, it may be 5%, but it’s not negative. Sometimes viability comes in four years or six years, not with the first hundred patients.”
Investments in advanced care often take time to demonstrate their full potential, particularly when capabilities are being built in new markets.
For hospitals, the definition of value is expanding. Total cost of care offers a broader view than the cost of a single procedure, while clinical outcomes and patient experience provide additional measures of impact. Trust is equally important. Positive patient experiences, word-of-mouth referrals and returning patients can all reflect the long-term value created by better care.
Ultimately, the conversation about technology comes back to access. Advanced healthcare cannot remain concentrated in a few metropolitan centres. The goal must be to ensure that patients in tier-two and tier-three cities also have access to safe, clinically proven and high-quality care. Achieving this will require stronger collaboration across the healthcare ecosystem, supported by training, infrastructure, affordability, digital connectivity, clinical capability and standardization. Outcome- and quality-linked approaches from payers can also help accelerate adoption.
Looking ahead, technology has the potential to enable a more connected patient journey. Greater interoperability across health data sources could give hospitals a more complete picture of each patient and support more predictive, personalized care. At the same time, technology and standardized clinical practices can help ensure that the quality of care a patient receives is less dependent on geography or the institution they enter.
The opportunity, therefore, is not only to develop more advanced technologies, but to build the ecosystem needed to translate those technologies into meaningful outcomes. That means bringing together clinicians, hospital leaders, technology companies, payers and other stakeholders around a shared focus on adoption, quality, sustainability and access.
Ultimately, the future of healthcare is not about having the most advanced technology. It is about ensuring that the right technology, in the right hands, reaches the right patient at the right time and creates better outcomes that can be sustained and scaled.
Disclaimer: The above content is non-editorial, and TIL hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
